SLP Simulations Plus Inc: Earnings per share for the last twelve months

Public company logo of Simulations Plus Corp (SLP)

Simulations Plus, Inc. (SLP) operates within its own business cycle, independent of global economic fluctuations, which transforms it into a reliable defensive asset. The asset's market valuation trend on the GURU.Markets platform, where the indicator stands at 112.80, confirms the success of the strategy to implement digital simulations as a replacement for real-world pharmacological testing. Simulations Plus, Inc. (SLP) generates revenue through the sale of specialized software and high-margin B2B subscriptions for drug modeling systems.

SLP Simulations Plus Inc. Net earnings per share for the last 12 months (02/11/2024 - 10/18/2026)

SLP (Simulations Plus Corp): analytical breakdowns and indicator data

- current quotes and average value forecast:
Stock Price simulations-plus.com|SLP - Price Target Chart
- company stock capitalization data:
Market Value Simulations Plus Inc|SLP - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Simulations Plus|SLP - Company Net Assets|Market Cap to Book Value Multiple simulations-plus.com|SLP - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Coefficient Simulations Plus, Inc.|SLP - Long-Term Debt to Equity|Current Liabilities to Capital Simulations Plus Inc.|SLP - Company Debts|Debt to Book Value Ratio Simulations Plus Inc|SLP - Company Long-Term Debt|Short-Term Debt Volume Simulations Plus|Intermediate Coverage Ratio simulations-plus.com
- earnings and multiples data:
SLP - Company Net Income|Forward Earnings Simulations Plus, Inc.|SLP - Price to Earnings Ratio|Future Price to Earnings Simulations Plus Inc|SLP - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Simulations Plus Inc|SLP - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Simulations Plus|SLP - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months simulations-plus.com|SLP - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Simulations Plus, Inc.
Initial company analysis:simulations-plus.com, SLP
Original product of Simulations Plus

This metric measures the dynamics of net income per share over the last twelve months relative to the same period last year. Analyzing the EPS YoY growth rate (trailing 12 months) allows an investor to assess the sustainability of fundamental momentum and identify signs of slowing growth. The current value of 112.80 reflects the efficiency of the business capitalization. Stable demand for medical research makes Simulations Plus, Inc. (SLP) a defensive asset, independent of global macroeconomic fluctuations.

Competitor analysis

VEEV - Net earnings per share (EPS TTM)|Doximity (DOCS) - Earnings per share for the last twelve months|HQY (HealthEquity Inc) - Earnings per share for the last twelve months|WAY (Waystar Inc.) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) CorVel Corp.|Net earnings per share for the last 12 months PRVA (Privia Health Group)|Earnings per share for the last four quarters HURN|Net earnings per share (EPS TTM) CERT (Certara)|Net earnings per share for the last four quarters Omnicell Inc (OMCL)|GDRX - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Schrodinger Corp|Phreesia, Inc. (PHR) - Earnings per share for the last twelve months|Earnings per share for the last 12 months OMDA|Earnings per share for the last twelve months Evolent Health|HealthStream Inc (HSTM) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months DH (Definitive Healthcare Inc.)|CCSI (Consensus Corp) - Earnings per share for the trailing year|Earnings per share for the last twelve months Agilon Health AGL|ABSI (absci.com) - Earnings per one share for the last 12 months|SY - Earnings per share for the last twelve months|NRC: Earnings per share for the last twelve months|SPOK (Spok Corp) - Net earnings per share for the last 12 months|OptimizeRx Inc. (OPRX) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months TruBridge, Inc.|SOPHiA GENETICS S.A. (SOPH) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HCAT (Health Catalyst)|CCLD (carecloud.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RSSS (Research Solutions)|Net earnings per share for the last four quarters DLH Corp (DLHC)|ONMD - Earnings per share for the last twelve months|SCNX (scienture.com) - Earnings per share for the last 12 months|HCTI: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months iSpecimen|Net earnings per share for the last 12 months BFRG|SCWorx Inc (WORX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months MSP Recovery Inc (MSPR)|Net earnings per share for the last four quarters icoreconnect.com|Earnings per share for the last twelve months TRxADE HEALTH MEDS|Orgenesis Inc - Earnings per share for the last twelve months|RCM - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SHCR|STRM: Net earnings per share (EPS TTM)|SYRA - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months AMEH|MODN (Model N Inc) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months NXGN (NextGen)